Real-time disaster intelligence, alerts, and response tools.
Tuesday, April 21, 2026
[ad_1] Implantable Neuromodulation System Shows Early Promise in Improving Patient Quality of Life by Reducing Monthly Headache Days and Severity of Migraine Attacks MINNEAPOLIS, Oct. 9, 2024 /PRNewswire/ — ShiraTronics, a clinical-stage medical device company […]
[ad_1] First-of-its-kind survey shows primary care physicians and public have low awareness, low concerns despite global surge in life-threatening mosquito-borne diseases lacking effective therapies or vaccines NEW YORK, Oct. 9, 2024 /PRNewswire/ — Cure®, a healthcare […]
[ad_1] COPENHAGEN, Denmark, Oct. 9, 2024 /PRNewswire/ — Antag Therapeutics, a leading biopharmaceutical company focused on targeting the Glucose-Dependent Insulinotropic Polypeptide (GIP) receptor to pioneer novel treatments for obesity, today announced that the U.S. Food […]
[ad_1] Deep expertise in leading drug discovery programs across oncology, neuroscience and epigenetics Will drive advancement of Curve’s rich pipeline of first-in-class therapeutic assets Builds on recent leadership team appointments, including Andre Hoekema as Chair […]
[ad_1] BOSTON and OKLAHOMA CITY, Oct. 9, 2024 /PRNewswire/ — Wheeler Bio, an agile and boutique contract development and manufacturing organization (CDMO), today announced the appointment of Patrick Lucy as Chief Executive Officer. Patrick joins […]
